Sartorius Stedim Biotech.
Open
SectorFinance
190.7 -4.22
Overview
Share price change
24h
Min
195.3
Max
203
Income | 4.9M 93M |
|---|---|
Sales | 4.2M 766M |
P/E Sector Avg | 65.116 21.623 |
EPS | 1.25 |
Dividend yield | 0.35 |
Profit margin | 12.146 |
Employees | 10,477 |
EBITDA | 9.2M 240M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +17.82% upside |
Dividend yield Sector Avg | 0.35% 4.44% |
|---|---|
Next Earnings | 22 paź 2026 |
Market Cap | 1.5B 19B |
|---|---|
Previous open | 194.92 |
Previous close | 190.7 |
News Sentiment
By Acuity
50%
50%
184 / 436 Ranking in Finance
Sartorius Stedim Biotech. Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Sartorius Stedim Biotech. Forecast
Price Target
By TipRanks
12 Months Forecast
Average 234 EUR 17.82%
High 260 EUR
Low 210 EUR
Based on 5 Wall Street analysts offering 12 month price targets forSartorius Stedim Biotech. - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$